# Trade Mark Journal No.2025/025 20 June 2025

## UK00004214557 5 June 2025 (10,44)

International priority date claimed: 16 December 2024 (United States of America) (98/905032)

Class 10
  Medical testing kit comprised primarily of blood collecting tubes and bags, holder for medical sample tubes, vials and desiccant for testing blood for assessing the likelihood of patient outcomes and medical treatments; medical diagnostic apparatus for testing biological specimens, namely, molecular diagnostic tests which use molecular tools, mass spectrometry, enzyme-linked immunosorbent assays and algorithms to test biological specimens for the presence of biomarkers, to assist in assessing the likelihood of malignancy.
Class 44
  Diagnostic testing services that may be ordered by health care providers to provide information for medical treatment or medical treatment decisions for patients; medical testing services for testing biological specimens for the presence of biomarkers to assist in assessing the likelihood of malignancy for diagnostic or treatment purposes; Assay development and validation for biomarkers, testing, kitting and sample storage, and diagnostic commercialization.

Biodesix, Inc.

Representative: Cleveland Scott York